Human genetic disorders involving glycosylphosphatidylinositol (GPI) anchors and glycosphingolipids (GSL)

Journal of Inherited Metabolic Disease

Volumn 38, Issue 1, 2015, Pages 171-178

  Ng, Bobby G ^a   Freeze, Hudson H ^a  

^a BURNHAM INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOHYDRATE; GLYCOSPHINGOLIPID; GLYCOSYLPHOSPHATIDYLINOSITOL;

ANIMAL; CHEMISTRY; DNA SEQUENCE; GLYCOSYLATION; HIGH THROUGHPUT SEQUENCING; HUMAN; HUMAN GENOME; MUTATION; PHENOTYPE;

ANIMALS; CARBOHYDRATES; GENOME, HUMAN; GLYCOSPHINGOLIPIDS; GLYCOSYLATION; GLYCOSYLPHOSPHATIDYLINOSITOLS; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MUTATION; PHENOTYPE; SEQUENCE ANALYSIS, DNA;

EID: 84920097099     PISSN: 01418955     EISSN: 15732665     Source Type: Journal    
DOI: 10.1007/s10545-014-9752-1     Document Type: Review

References (50)

1. Almeida AM, Murakami Y, Layton DM et al (2006) Hypomorphic promoter mutation in PIGM causes inherited glycosylphosphatidylinositol deficiency. Nat Med 12(7):846–851
2. Almeida AM, Murakami Y, Baker A et al (2007) Targeted therapy for inherited GPI deficiency. N Engl J Med 356(16):1641–1647
3. Ashida H, Hong Y, Murakami Y et al (2005) Mammalian PIG-X and yeast Pbn1p are the essential components of glycosylphosphatidylinositol-mannosyltransferase I. Mol Biol Cell 16(3):1439–1448
4. Belet S, Fieremans N, Yuan X et al (2014) Early frameshift mutation in PIGA identified in a large XLID family without neonatal lethality. Hum Mutat 35(3):350–355
5. Boccuto L, Aoki K, Flanagan-Steet H et al (2014) A mutation in a ganglioside biosynthetic enzyme, ST3GAL5, results in salt & pepper syndrome, a neurocutaneous disorder with altered glycolipid and glycoprotein glycosylation. Hum Mol Genet 23(2):418–433
6. Boukhris A, Schule R, Loureiro JL et al (2013) Alteration of ganglioside biosynthesis responsible for complex hereditary spastic paraplegia. Am J Hum Genet 93(1):118–123
7. Brodsky RA, Mukhina GL, Li S et al (2000) Improved detection and characterization of paroxysmal nocturnal hemoglobinuria using fluorescent aerolysin. Am J Clin Pathol 114(3):459–466
8. Chiyonobu T, Inoue N, Morimoto M, Kinoshita T, Murakami Y (2014) Glycosylphosphatidylinositol (GPI) anchor deficiency caused by mutations in PIGW is associated with West syndrome and hyperphosphatasia with mental retardation syndrome. J Med Genet 51(3):203–207
9. Edvardson S, Baumann AM, Muhlenhoff M et al (2013) West syndrome caused by ST3Gal-III deficiency. Epilepsia 54(2):e24–e27
10. Ferguson MAJ, Kinoshita T, Hart GW (2009) Glycosylphosphatidylinositol Anchors. In: A Varki, RD Cummings, JD Esko, HH Freeze, P Stanley, CR Bertozzi, GW Hart, ME Etzler (eds) Essentials of glycobiology. Cold Spring Harbor, New York
11. Freeze HH, Chong JX, Bamshad MJ, Ng BG (2014) Solving glycosylation disorders: fundamental approaches reveal complicated pathways. Am J Hum Genet 94(2):161–175
12. Fujita M, Kinoshita T (2012) GPI-anchor remodeling: potential functions of GPI-anchors in intracellular trafficking and membrane dynamics. Biochim Biophys Acta 1821(8):1050–1058
13. Fujita M, Maeda Y, Ra M, Yamaguchi Y, Taguchi R, Kinoshita T (2009) GPI glycan remodeling by PGAP5 regulates transport of GPI-anchored proteins from the ER to the Golgi. Cell 139(2):352–365
14. Hansen L, Tawamie H, Murakami Y et al (2013) Hypomorphic mutations in PGAP2, encoding a GPI-anchor-remodeling protein, cause autosomal-recessive intellectual disability. Am J Hum Genet 92(4):575–583
15. Hong Y, Maeda Y, Watanabe R et al (1999) Pig-n, a mammalian homologue of yeast Mcd4p, is involved in transferring phosphoethanolamine to the first mannose of the glycosylphosphatidylinositol. J Biol Chem 274(49):35099–35106
16. Hong Y, Maeda Y, Watanabe R, Inoue N, Ohishi K, Kinoshita T (2000) Requirement of PIG-F and PIG-O for transferring phosphoethanolamine to the third mannose in glycosylphosphatidylinositol. J Biol Chem 275(27):20911–20919
17. Howard MF, Murakami Y, Pagnamenta AT et al (2014) Mutations in PGAP3 impair GPI-anchor maturation, causing a subtype of hyperphosphatasia with mental retardation. Am J Hum Genet 94(2):278–287
18. Hu H, Eggers K, Chen W et al (2011) ST3GAL3 mutations impair the development of higher cognitive functions. Am J Hum Genet 89(3):407–414
19. Johnston JJ, Gropman AL, Sapp JC et al (2012) The phenotype of a germline mutation in PIGA: the gene somatically mutated in paroxysmal nocturnal hemoglobinuria. Am J Hum Genet 90(2):295–300
20. Kang JY, Hong Y, Ashida H et al (2005) PIG-V involved in transferring the second mannose in glycosylphosphatidylinositol. J Biol Chem 280(10):9489–9497
21. Kato M, Saitsu H, Murakami Y et al (2014) PIGA mutations cause early-onset epileptic encephalopathies and distinctive features. Neurology 82(18):1587–1596
22. Krawitz PM, Schweiger MR, Rodelsperger C et al (2010) Identity-by-descent filtering of exome sequence data identifies PIGV mutations in hyperphosphatasia mental retardation syndrome. Nat Genet 42(10):827–829
23. Krawitz PM, Murakami Y, Hecht J et al (2012) Mutations in PIGO, a member of the GPI-anchor-synthesis pathway, cause hyperphosphatasia with mental retardation. Am J Hum Genet 91(1):146–151
24. Krawitz PM, Hochsmann B, Murakami Y et al (2013a) A case of paroxysmal nocturnal hemoglobinuria caused by a germline mutation and a somatic mutation in PIGT. Blood 122(7):1312–1315
25. Krawitz PM, Murakami Y, Riess A et al (2013b) PGAP2 mutations, affecting the GPI-anchor-synthesis pathway, cause hyperphosphatasia with mental retardation syndrome. Am J Hum Genet 92(4):584–589
26. Kuki I, Takahashi Y, Okazaki S et al (2013) Vitamin B6-responsive epilepsy due to inherited GPI deficiency. Neurology 81(16):1467–1469
27. Kvarnung M, Nilsson D, Lindstrand A et al (2013) A novel intellectual disability syndrome caused by GPI anchor deficiency due to homozygous mutations in PIGT. J Med Genet 50(8):521–528
28. Maeda Y, Watanabe R, Harris CL et al (2001) PIG-M transfers the first mannose to glycosylphosphatidylinositol on the lumenal side of the ER. EMBO J 20(1–2):250–261
29. Maeda Y, Ashida H, Kinoshita T (2006) CHO glycosylation mutants: GPI anchor. Methods Enzymol 416:182–205
30. Maeda Y, Tashima Y, Houjou T et al (2007) Fatty acid remodeling of GPI-anchored proteins is required for their raft association. Mol Biol Cell 18(4):1497–1506
31. Martin HC, Kim GE, Pagnamenta AT et al (2014) Clinical whole-genome sequencing in severe early-onset epilepsy reveals new genes and improves molecular diagnosis. Hum Mol Genet. doi:10.1093/hmg/ddu199
32. Maydan G, Noyman I, Har-Zahav A et al (2011) Multiple congenital anomalies-hypotonia-seizures syndrome is caused by a mutation in PIGN. J Med Genet 48(6):383–389
33. Murakami Y, Siripanyapinyo U, Hong Y et al (2003) PIG-W is critical for inositol acylation but not for flipping of glycosylphosphatidylinositol-anchor. Mol Biol Cell 14(10):4285–4295
34. Murakami Y, Kanzawa N, Saito K et al (2012) Mechanism for release of alkaline phosphatase caused by glycosylphosphatidylinositol deficiency in patients with hyperphosphatasia mental retardation syndrome. J Biol Chem 287(9):6318–6825
35. Murakami Y, Tawamie H, Maeda Y et al (2014) Null mutation in PGAP1 impairing Gpi-anchor maturation in patients with intellectual disability and encephalopathy. PLoS Genet 10(5):e1004320. doi:10.1371/journal.pgen.1004320
36. Ng BG, Hackmann K, Jones MA et al (2012) Mutations in the glycosylphosphatidylinositol gene PIGL cause CHIME syndrome. Am J Hum Genet 90(4):685–688
37. Ohba C, Okamoto N, Murakami Y et al (2014) PIGN mutations cause congenital anomalies, developmental delay, hypotonia, epilepsy, and progressive cerebellar atrophy. Neurogenetics 15(2):85–92
38. Ohishi K, Inoue N, Kinoshita T (2001) PIG-S and PIG-T, essential for GPI anchor attachment to proteins, form a complex with GAA1 and GPI8. EMBO J 20(15):4088–4098
39. Schnaar RL, Suzuki A, Stanley P (2009) Glycosphingolipids. In: A Varki, RD Cummings, JD Esko, HH Freeze, P Stanley, CR Bertozzi, GW Hart, ME Etzler (eds) Essentials of glycobiology. Cold Spring Harbor, New York
40. Schnaar RL, Gerardy-Schahn R, Hildebrandt H (2014) Sialic acids in the brain: gangliosides and polysialic acid in nervous system development, stability, disease, and regeneration. Physiol Rev 94(2):461–518
41. Simpson MA, Cross H, Proukakis C et al (2004) Infantile-onset symptomatic epilepsy syndrome caused by a homozygous loss-of-function mutation of GM3 synthase. Nat Genet 36(11):1225–1229
42. Swoboda KJ, Margraf RL, Carey JC et al (2014) A novel germline PIGA mutation in Ferro-Cerebro-Cutaneous syndrome: a neurodegenerative X-linked epileptic encephalopathy with systemic iron-overload. Am J Med Genet A 164A(1):17–28
43. Takahashi M, Inoue N, Ohishi K et al (1996) PIG-B, a membrane protein of the endoplasmic reticulum with a large lumenal domain, is involved in transferring the third mannose of the GPI anchor. EMBO J 15(16):4254–4261
44. Takeda J, Miyata T, Kawagoe K et al (1993) Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria. Cell 73(4):703–711
45. Tanaka S, Maeda Y, Tashima Y, Kinoshita T (2004) Inositol deacylation of glycosylphosphatidylinositol-anchored proteins is mediated by mammalian PGAP1 and yeast Bst1p. J Biol Chem 279(14):14256–14263
46. Tettamanti G, Bonali F, Marchesini S, Zambotti V (1973) A new procedure for the extraction, purification and fractionation of brain gangliosides. Biochim Biophys Acta 296(1):160–170
47. Thompson MD, Killoran A, Percy ME, Nezarati M, Cole DE, Hwang PA (2006) Hyperphosphatasia with neurologic deficit: a pyridoxine-responsive seizure disorder? Pediatr Neurol 34(4):303–307
48. Wakil SM, Monies DM, Ramzan K et al (2013) Novel B4GALNT1 mutations in a complicated form of hereditary spastic paraplegia. Clin Genet, doi: 10.1111/cge.12312
49. Watanabe R, Ohishi K, Maeda Y, Nakamura N, Kinoshita T (1999) Mammalian PIG-L and its yeast homologue Gpi12p are N-acetylglucosaminylphosphatidylinositol de-N-acetylases essential in glycosylphosphatidylinositol biosynthesis. Biochem J 339(Pt 1):185–192
50. Yang HS, Yang M, Li X, Tugulea S, Dong H (2013) Diagnosis of paroxysmal nocturnal hemoglobinuria in peripheral blood and bone marrow with six-color flow cytometry. Biomark Med 7(1):99–111